Thomas Owley

Thomas Owley

UNVERIFIED PROFILE

Are you Thomas Owley?   Register this Author

Register author
Thomas Owley

Thomas Owley

Publications by authors named "Thomas Owley"

Are you Thomas Owley?   Register this Author

14Publications

494Reads

27Profile Views

Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.

Pharmacogenet Genomics 2015 Nov;25(11):548-54

aDepartment of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy bDepartment of Psychiatry, University of Minnesota College of Medicine, Minneapolis, Minnesota cDepartment of Psychiatry, University of Illinois at Chicago College of Medicine, Chicago, Illinois dDepartments of Psychiatry and Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591203PMC
November 2015

Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism.

J Child Adolesc Psychopharmacol 2015 Aug;25(6):467-74

6 Department of Experimental and Clinical Pharmacology, University of Minnesota , Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cap.2014.0158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544820PMC
August 2015

A pharmacogenetic study of escitalopram in autism spectrum disorders.

Autism Res 2010 Feb;3(1):1-7

Department of Psychiatry, Institute for Juvenile Research, University of Illinois at Chicago, 1747 West Roosevelt Road, Chicago, IL 60608, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/aur.109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937270PMC
February 2010

A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders.

J Child Adolesc Psychopharmacol 2006 Oct;16(5):517-24

University of Illinois at Chicago, Department of Psychiatry, Institute for Juvenile Research, Chicago, Illinois 60608, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cap.2006.16.517DOI Listing
October 2006

An open-label trial of escitalopram in pervasive developmental disorders.

J Am Acad Child Adolesc Psychiatry 2005 Apr;44(4):343-8

Department of Psychiatry, University of Chicago MC 3077, 5841 South Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S089085670961485
Publisher Site
http://dx.doi.org/10.1097/01.chi.0000153229.80215.a0DOI Listing
April 2005

EPS or stereotypies?

J Child Adolesc Psychopharmacol 2005 Apr;15(2):150-1; author reply 152

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cap.2005.15.150DOI Listing
April 2005

Impact of recent findings on study design of future autism clinical trials.

CNS Spectr 2004 Jan;9(1):49-56

Department of Psychiatry, Mount Sinai School of Medicine, New York City, New York 10029-6574, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s109285290000835xDOI Listing
January 2004

Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder.

J Child Adolesc Psychopharmacol 2002 ;12(2):165-71

Section of Child and Adolescent Psychiatry, Department of Psychiatry, University of Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/104454602760219207DOI Listing
January 2003

The pharmacological treatment of autistic spectrum disorders.

Authors:
Thomas Owley

CNS Spectr 2002 Sep;7(9):663-9

Department of Psychiatry, Division of Child and Adolescent Psychiatry, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s109285290002215xDOI Listing
September 2002